Search Results

Your search matched 35 results

  • 1
  • 2
#1

AI Predicts Drug Interactions Like We Never Could | Blog

Complications from drug interactions can present patients with whole new afflictions.

#2

Approved: First CBD-based Prescription Drug, for Treatment of Epilepsy | Blog

A landmark approval by the FDA will put the first marijuana-derived prescription drug behind pharmacy counters this fall.

#3

Geisinger CEO Poached by Google to Drive Healthcare Strategy | Blog

After taking some major leaps into healthcare, Google has begun solidifying its foothold in the space by appointing Dr.

#4

WalMart May Enlist Doctors to Help Beat Amazon in Tug-of-War | Blog

To retail behemoths, the health care realm is growing irresistible.

#5

If You’ve Been the Victim of Medical Malpractice, Don’t Yelp About It | Blog

The State Supreme Court just resolved a 10-year battle between the Cleveland Clinic and a former patient, retired U.S.

#6

Zipline Drones Achieve Universal Health Care Delivery in Rwanda. | Blog

With funding from Google, Stanford, and venture capital giants Sequoia and Andreessen Horowitz, seven-year-old Zipline has already revolutionized health care in Rwanda.

#7

Orphan Drugs More Promising than Ever | Blog

The growing appeal of orphan drugs to manufacturers isn’t a groundbreaking story, but a new report identifies some head-spinning facts behind the focal shift from blockbuster to rare-disease drugs.

#8

More Clinical Trials for More Women Thanks to Advantia, Elligo | Blog

Advantia Health, a leading-edge medical company committed to empowering women with integrated health care services, announced a new partnership with Elligo Health Research, which will offer Advantia’s clients access to a whole new realm of resources, through clinical trials.

#9

Cannabis Firm Tilray Scores Partnership with Novartis | Blog

Tilray, a medical-cannabis producer, has established a new partnership with pharmaceutical giant Novartis, affording the former sales and distribution channels in tens of new countries.

#11

Roche’s “Floodlight” a Multiple Sclerosis Game Changer | Blog

Pharmaceutical giant Roche’s new app for people with multiple sclerosis (MS) revolutionizes how doctors care for patients with the disease.

#12

Alexa, Upend My Fixed Conceptions of Healthcare in America | Blog

Beginning with its acquisition of PillPack, Amazon’s grand entrance into healthcare continues with its partnership with J.P.

#13

Psychiatric Trials Supercharged by Otsuka’s Science 37 Collab | Blog

Holistic healthcare brand Otsuka Pharmaceutical has announced a promising partnership with Science 37, the trailblazing startup out of MIT that’s transforming clinical trials for everyone.

#14

Lyft Offering (Some) Free Rides to the Hospital | Blog

Nonprofit hospital system Partners HealthCare has unveiled a joint venture with Circulation, an on-demand rideshare service, through which Medicare patients receive free rides to their doctor’s offices in non-emergencies.

#15

Big Healthcare Brands Warming to Blockchain | Blog

A new Deloitte report explores the near-future of blockchain: how seriously the world’s top executives, including many in healthcare, regard the emerging technology and how soon they might invest in it.

#16

In Return for Your Foodstagrams, Your Blood, and Your DNA, Nestlé Offering Smoothies | Blog

Nestlé, the brand you might associate first with such decadent confections as Crunch bars, Laffy Taffy, and Toll House cookies, has made a decided turn toward the healthful.

#17

Pfizer, Novartis Align Against Liver Disease | Blog

Pfizer and Novartis have been independently developing therapies for nonalcoholic steatohepatitis (NASH), and they’re now set to join forces to yield a combination therapy for the fatty liver disease linked closely with metabolic disorders.

#18

Pharmacists Reduce Opioid Use by 50% in Kaiser Permanente Study | Blog

In a telling new study, pre- and post-surgical efforts by pharmacists yielded staggering effects on patient opioid use.

#19

Novartis, J&J, and Merck Find Brand-New Data, Showcase Big Healthcare Shifts as Described in the 2019 Health Trend Ten from Syneos Health | Blog

Forecasting next year’s biggest shifts within the healthcare landscape, Syneos Health has released 2019 Health Trend Ten, available for download now, which explicates ten of the trends that will redefine healthcare globally.

#20

Medical Data Processing Disrupted by Amazon | Blog

Amazon Web Services (AWS) has unveiled new machine-learning tools reflecting—and beginning to tackle—some of the greatest challenges facing modern medicine.

#21

GSK Gains Targeted Therapy, Footing in Boston with $5.1-billion Tesaro Buy | Blog

GlaxoSmithKline announced that it will acquire Waltham, Massachusetts-based drug company Tesaro, which develops novel cancer treatments, for $5.1 billion cash.

#22

Why Innovation and Marketing Need to Happen in Tandem | Blog

In a new Harvard Business Review article, brand positioning expert Denise Lee Yohn distills some of the most useful marketing points gleaned from her 25 years of marketing leadership.

#23

Apps to Push Prescription Drugs Over the Counter | Blog

In the first half of this new year, the United States FDA will incentivize many pharmaceutical brands to make their biggest prescription drugs available over the counter.

#24

Novartis Reps Have A.I. that Knows Exactly What to Say | Blog

As the use of artificial intelligence in R&D continues to rise, Novartis takes it even further, equipping its reps with AI that suggests the perfect things to talk about with HCPs.

#25

Amazon Deploys Legion of Micro-influencers, Accepting Applications for More | Blog

While the term “micro-influencer” may still sound to you like some flippant, gen-Z farce, the side hustle cum way of life just scored serious validation.

#26

Patients Who Use New PreHab App Spend Less Time in Hospital | Blog

Digital health company Peerwell created an app to prepare patients for surgery and, in turn, reduce the amount of time they spend in the hospital.

#28

Alternative Research by Wyoming Biologist May Yield Alzheimer’s Treatment | Blog

Not your typical geotag for pharmaceutical innovation, Jackson Hole and its most prominent biologist, Paul Cox, may turn decades’ and billions of dollars’ worth of Alzheimer’s research on its head.

#29

F.D.A. | Blog

An expert panel that advises U.S. federal regulatory authorities has recommended approval of Esketamine, Johnson & Johnson’s brand-new treatment for depression.

#30

Digital Medicine & MedTech Showcase: What Does a Clinical Trial Look Like for Digital Therapeutics? | Blog

Digital therapeutics, or DTx, are distinct from digital health products, and are driven by software programs that can be prescribed to prevent, manage, or treat a medical disorder or disease, as stated by the Digital Therapeutics Alliance.

  • 1
  • 2